The relevance of PTPs in sustaining melanoma aggressiveness is further confirmed by tests carried out on mice xenografted with melanoma cells, revealing that treatment with PTPs inhibitors impairs proliferation, migration, and invasiveness of cancer cells [116,130], and enhances the antitumoral immune response [154,205,206,226]. The gene discussed is PTS; the disease is melanoma.